Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome - Test2 - elhamkhani - TriplyDB

Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome

Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome

http://www.wikidata.org/entity/Q35375182

about

Fragmented ECG as a risk marker in cardiovascular diseases Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease.

P2860

Q26862725-CEC83FEC-9D88-4077-B0A1-7DDF5A4B3E58 Q33160170-F4B898F8-D959-4BEE-9EC2-2594F46B1491 Q44459153-A492A22F-FA4F-4FAF-86D5-A5347247146B

P2860

Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome

http://www.wikidata.org/entity/Q35375182

description

2000 nî lūn-bûn

@nan

2000 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մարտին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Effects of cardiac sympathetic ...... patients with long QT syndrome

@ast

Effects of cardiac sympathetic ...... patients with long QT syndrome

@en

type

label

Effects of cardiac sympathetic ...... patients with long QT syndrome

@ast

Effects of cardiac sympathetic ...... patients with long QT syndrome

@en

prefLabel

Effects of cardiac sympathetic ...... patients with long QT syndrome

@ast

Effects of cardiac sympathetic ...... patients with long QT syndrome

@en

P1433

Q35375182-F9443F38-6335-4F5F-B45A-A18C0C7ACD29

P1476

Q35375182-875DFD19-1ED8-4CC9-A6BD-1E58371FDF7C

P2093

Q35375182-43EEE4D0-A49F-4327-89BF-A711765B99EB

Q35375182-590E049C-4B82-4727-B8EC-17C856FD1EA3

Q35375182-5D66AE47-E0C0-4D4F-9B26-59500EE3FC98

Q35375182-B02E54D7-1EBF-420C-A737-17BF78174FAF

Q35375182-B09EDA70-8DA8-4C72-B7F4-A91148B4434D

Q35375182-B4FF7B3D-01D8-4646-84F7-D5099FF14E91

Q35375182-CC49206C-825F-4FBE-B8CF-04A3AA71EAD5

Q35375182-F7CD4251-97EA-434F-A722-D7AE0FEEE83E

P2860

Q35375182-0C24D34E-5786-4B38-8DBD-980B27FD0FAB

Q35375182-0D3F7224-82E3-4A83-90DF-8FF46FE51AEA

Q35375182-2128A5C1-66AD-4F43-B827-075C9766AE42

Q35375182-42856133-052A-4A97-9DCC-091E26E3665E

Q35375182-5DFA157D-D659-4ED9-BC0B-88F35617337C

Q35375182-5EBEC8BB-0984-46B4-9043-EE49A00F9B40

Q35375182-6984749B-E3CB-493F-9553-6F4F67F096F7

Q35375182-6D5D32D1-EA3D-4586-8627-D8AC448E9AC5

Q35375182-6EDE6C83-3C6C-4B85-A6A3-516FAB7126D3

Q35375182-858D237D-50E6-4888-B929-022FC6732F2A

P304

Q35375182-3F2BC269-0864-48BF-9D9E-3FF7D1019449

P31

Q35375182-DA94F66D-D6E9-44FC-A9A9-208D382F9D8B

P356

Q35375182-CDBD0C93-CFB6-4CB1-991F-978ED1CB5DD0

P407

Q35375182-2071196A-0A93-4382-AF7B-5067FE2CC6CF

P433

Q35375182-B8CA75AE-63B9-4B80-90CB-819AD7DD7C5E

P478

Q35375182-53CB6034-0899-4EA4-A6A6-6B8C620CBBF1

P577

Q35375182-07338155-E14F-4FA1-BAEC-CFDAF3BC232D

P5875

Q35375182-D99D6577-444A-469C-9DC6-0D783891BEE5

P698

Q35375182-7AE3BCBB-2E2D-4A86-AF2C-CBA5B1477F7A

P932

Q35375182-600D3084-A021-4500-A6F3-2463A6405E05

P356

P1433

P1476

Effects of cardiac sympathetic ...... patients with long QT syndrome

@en

P2093

Emori T

http://www.w3.org/2001/XMLSchema#string

Fukushima K

http://www.w3.org/2001/XMLSchema#string

Matsubara H

http://www.w3.org/2001/XMLSchema#string

Miyazi K

http://www.w3.org/2001/XMLSchema#string

Morita H

http://www.w3.org/2001/XMLSchema#string

Nakayama K

http://www.w3.org/2001/XMLSchema#string

Ohe T

http://www.w3.org/2001/XMLSchema#string

Yamanari H

http://www.w3.org/2001/XMLSchema#string

P2860

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

Congenital myocardial sympathetic dysinnervation (CMSD)--a structural defect of idiopathic long QT syndrome.

Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications.

The long Q-T syndrome.

Idiopathic long QT syndrome: progress and questions.

Molecular mechanism for an inherited cardiac arrhythmia.

Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome.

Dispersion of regional wall motion abnormality in patients with long QT syndrome

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).

P304

295-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEART.83.3.295

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277395802

http://www.w3.org/2001/XMLSchema#string

P698

10677409

http://www.w3.org/2001/XMLSchema#string

P932

1729335

http://www.w3.org/2001/XMLSchema#string